RNA, 7SL, cytoplasmic 268, pseudogene (RN7SL268P)

RNA, 7SL, cytoplasmic 268, pseudogene (RN7SL268P) is classified as a pseudogene based on homology to the functional 7SL RNA (also called signal recognition particle RNA) gene family[3][5]. The 7SL RNA is a non-coding RNA critical for the function of the signal recognition particle (SRP), which mediates cotranslational protein targeting to the endoplasmic reticulum in eukaryotes[5][6]. However, the vast majority of 7SL-like sequences in the human genome, including RN7SL268P, are truncated or mutated copies of the original gene and do not encode a functional product[3][5]. They have arisen through the reverse transcription of 7SL RNA and integration back into genomic DNA at multiple sites, often lacking sequence elements necessary for stable or functional RNA expression[3]. RN7SL268P itself is not a functional gene and does not encode a protein, participate in cell signaling, or serve as a therapeutic target. It is not implicated in any disease processes, is not known to interact with drugs, and has no recognized biomarker or safety concern relevance. The existence of multiple related pseudogenes in the human genome is a result of the evolutionary mobility of 7SL sequences and their connection to the origin of Alu repetitive elements in primates[5]. RN7SL268P is a nonfunctional 7SL RNA pseudogene, not a therapeutic target or true gene; has no disease, drug, or biomarker relevance, and is a relic of genomic evolution. The entry is likely not a therapeutic target due to its pseudogene status. Its utility is restricted to evolutionary and genomic studies, not biomedical targeting.

Other names

RN7SL268P